Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the EBITDA margin high or low?
The EBITDA margin of -234.91% is 14% above its 5-year average of -271.76%, around the middle of its 5-year range (-613.17%–50.32%).
18.55% above its 12-month average of -288.40%.
Reported quarterly EBITDA margin; no daily interpolation. Q2 FY2026 (2026-06-30): -416.40%.
EBITDA MARGIN
-234.91%
EBITDA MARGIN AVG TTM
-288.40%
EBITDA MARGIN AVG 3Y
-220.16%
EBITDA MARGIN AVG 5Y
-271.76%
EBITDA MARGIN AVG 10Y
-245.78%
EBITDA MARGIN AVG 15Y
-198.06%
EBITDA MARGIN AVG 20Y
-162.46%
CURRENT VS TTM AVG
+18.55%
CURRENT VS 3Y AVG
-6.70%
CURRENT VS 5Y AVG
+13.56%
CURRENT VS 10Y AVG
+4.42%
CURRENT VS 15Y AVG
-18.61%
CURRENT VS 20Y AVG
-44.59%
Nektar Therapeutics
Market Cap
$1.15B
EBITDA Margin
-234.91%
TTM Avg
-288.40%
3Y Avg
-220.16%
5Y Avg
-271.76%
Market Cap
$1.15B
EBITDA Margin
21.67%
TTM Avg
19.38%
3Y Avg
14.20%
5Y Avg
2.75%
Market Cap
$1.13B
EBITDA Margin
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$1.13B
EBITDA Margin
28.28%
TTM Avg
32.08%
3Y Avg
32.10%
5Y Avg
26.80%
Market Cap
$1.13B
EBITDA Margin
21.12%
TTM Avg
16.04%
3Y Avg
11.58%
5Y Avg
9.26%
Market Cap
$1.12B
EBITDA Margin
-20.99%
TTM Avg
-14.27%
3Y Avg
-11.56%
5Y Avg
-5.13%
Market Cap
$1.10B
EBITDA Margin
-15.54%
TTM Avg
-15.54%
3Y Avg
-2.35%
5Y Avg
5.20%
| NAME | MARKET CAP | EBITDA MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Nektar Therapeutics (NKTR) | $1.15B | -234.91% | -288.40% | -220.16% | -271.76% |
| GoodRx Holdings, Inc. (GDRX)vs › | $1.15B | 21.67% | 19.38% | 14.20% | 2.75% |
| Damora Therapeutics, Inc. (DMRA)vs › | $1.17B | N/A | N/A | N/A | N/A |
| Avalyn Pharma Inc. Common Stock (AVLN)vs › | $1.13B | N/A | N/A | N/A | N/A |
| Amphastar Pharmaceuticals, Inc. (AMPH)vs › | $1.13B | 28.28% | 32.08% | 32.10% | 26.80% |
| Harrow Health, Inc. (HROW)vs › | $1.13B | 21.12% | 16.04% | 11.58% | 9.26% |
| OPKO Health, Inc. (OPK)vs › | $1.12B | -20.99% | -14.27% | -11.56% | -5.13% |
| STAAR Surgical Company (STAA)vs › | $1.10B | -15.54% | -15.54% | -2.35% | 5.20% |
| Replimune Group, Inc. (REPL)vs › | $1.10B | N/A | N/A | N/A | N/A |
| MannKind Corporation (MNKD)vs › | $1.22B | 14.64% | 21.61% | -2.02% | -22.43% |
Gross Margin
99.4%
EBITDA Margin
-234.9%
Operating Margin
-240.4%
Net Margin
-287.8%
Formula: EBITDA Margin = (EBITDA / Revenue) × 100
Why EBITDA Margin matters:
EBITDA Margin = EBITDA / Revenue
EBITDA margin measures operating profitability before interest, taxes, depreciation, and amortization as a percentage of revenue.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EBITDA MARGIN |
|---|---|
| 2026-06-30 | -416.40% |
| 2026-03-31 | -350.86% |
| 2025-12-31 | -86.67% |
| 2025-09-30 | -265.78% |
| 2025-06-30 | -322.29% |
| 2025-03-31 | -421.69% |
| 2024-12-31 | 50.32% |
| 2024-09-30 | -138.25% |
| 2024-06-30 | -205.69% |
| 2024-03-31 | -156.29% |
| 2023-12-31 | -133.38% |
| 2023-09-30 | -178.80% |
| 2023-06-30 | -236.27% |
| 2023-03-31 | -613.17% |
| 2022-12-31 | -174.99% |
| 2022-09-30 | -147.28% |
| 2022-06-30 | -200.83% |
| 2022-03-31 | -448.61% |
| 2021-12-31 | -442.32% |
| 2021-09-30 | -441.30% |
| 2021-06-30 | -376.48% |
| 2021-03-31 | -447.62% |
| 2020-12-31 | -458.09% |
| 2020-09-30 | -332.32% |
| 2020-06-30 | -152.56% |
| 2020-03-31 | -165.98% |
| 2019-12-31 | -313.22% |
| 2019-09-30 | -326.13% |
| 2019-06-30 | -462.86% |
| 2019-03-31 | -416.73% |
| 2018-12-31 | -244.12% |
| 2018-09-30 | -345.62% |
| 2018-06-30 | 89.75% |
| 2018-03-31 | -221.47% |
| 2017-12-31 | -22.39% |
| 2017-09-30 | 47.92% |
| 2017-06-30 | -134.15% |
| 2017-03-31 | -203.83% |
| 2016-12-31 | -75.55% |
| 2016-09-30 | -79.90% |
| 2016-06-30 | -105.00% |
| 2016-03-31 | -9.80% |
| 2015-12-31 | -65.07% |
| 2015-09-30 | 6.16% |
| 2015-06-30 | -179.20% |
| 2015-03-31 | 42.29% |
| 2014-12-31 | -175.41% |
| 2014-09-30 | 62.87% |
| 2014-06-30 | -68.95% |
| 2014-03-31 | -167.61% |
| 2013-12-31 | -104.35% |
| 2013-09-30 | -4.80% |
| 2013-06-30 | -85.50% |
| 2013-03-31 | -181.60% |
| 2012-12-31 | -186.65% |
| 2012-09-30 | -158.90% |
| 2012-06-30 | -99.29% |
| 2012-03-31 | -191.94% |
| 2011-12-31 | -196.05% |
| 2011-09-30 | -64.88% |
| 2011-06-30 | -175.82% |
| 2011-03-31 | -265.61% |
| 2010-12-31 | -36.38% |
| 2010-09-30 | -5.43% |
| 2010-06-30 | 14.22% |
| 2010-03-31 | 2.38% |
| 2009-12-31 | -4.33% |
| 2009-09-30 | -245.94% |
| 2009-06-30 | -205.85% |
| 2009-03-31 | -274.77% |
| 2008-12-31 | 111.77% |
| 2008-09-30 | -130.56% |
| 2008-06-30 | -135.65% |
| 2008-03-31 | -181.03% |
| 2007-12-31 | 65.72% |
| 2007-09-30 | -21.44% |
| 2007-06-30 | -31.14% |
| 2007-03-31 | -21.90% |
| 2006-12-31 | -46.12% |
| 2006-09-30 | -25.35% |
| 2006-06-30 | -91.21% |
| 2006-03-31 | -84.83% |
| 2005-12-31 | -305.74% |
| 2005-09-30 | -47.00% |
| 2005-06-30 | -71.11% |
| 2005-03-31 | -64.87% |
| 2004-12-31 | -38.77% |
| 2004-09-30 | -51.06% |
| 2004-06-30 | -57.58% |
| 2004-03-31 | -44.87% |
| 2003-12-31 | -59.61% |
| 2003-09-30 | -35.53% |
| 2003-06-30 | -35.33% |
| 2003-03-31 | -50.81% |
| 2002-12-31 | -109.32% |
| 2002-09-30 | -83.82% |
